- ISIN
- US59156R1086
- CUSIP
- 59156R108
- Sector
- Financial Services
- Industry
- Insurance - Life
- IPO Date
- Apr 5, 2000
Highlights
- EPS (TTM)
- $7.21
- PE Ratio
- 12.15
- PEG Ratio
- 0.41
- Total Revenue (TTM)
- $76.95B
- Gross Profit (TTM)
- $14.75B
- EBITDA (TTM)
- $4.11B
- Year Range
- $67.33 - $89.62
- Target Price
- $96.50
- ROA (TTM)
- 0.49%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
MET Performance Chart
MetLife, Inc. (MET) is up 12.6% since the beginning of the year. At $88 per share, MET is trading just below its 52-week high of $90. Investors who bought $1,000 worth of MET shares 5 years ago would now be looking at an investment worth $1,721.
Loading charts...
Returns By Period
MetLife, Inc. (MET) has returned 12.57% so far this year and 13.86% over the past 12 months. Looking at the last ten years, MET has achieved an annualized return of 14.63%, outperforming the S&P 500 Index benchmark, which averaged 13.88% per year.
MetLife, Inc.
- 1D
- 2.31%
- 1M
- 4.16%
- YTD
- 12.57%
- 6M
- 9.23%
- 1Y
- 13.86%
- 3Y*
- 21.60%
- 5Y*
- 11.47%
- 10Y*
- 14.63%
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
MET Monthly Returns History
Based on dividend-adjusted daily data since Apr 5, 2000, MET's average daily return is +0.07%, while the average monthly return is +1.21%. At this rate, an investment would double in approximately 4.8 years.
Historically, 57% of months were positive and 43% were negative. The best month was Apr 2009 with a return of +30.7%, while the worst month was Oct 2008 at -40.7%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 5 months.
On a daily basis, MET closed higher 51% of trading days. The best single day was Sep 30, 2008 with a return of +28.0%, while the worst single day was Oct 8, 2008 at -26.8%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -0.08% | -7.98% | -1.87% | 13.26% | 4.02% | 5.89% | 12.57% | ||||||
| 2025 | 5.65% | 0.26% | -6.83% | -6.13% | 5.03% | 2.34% | -5.56% | 7.94% | 1.24% | -3.10% | -3.39% | 3.11% | -0.80% |
| 2024 | 4.82% | 1.41% | 6.27% | -4.09% | 2.61% | -3.01% | 9.49% | 1.63% | 6.45% | -4.92% | 13.30% | -7.20% | 27.68% |
| 2023 | 0.90% | -1.06% | -19.22% | 5.85% | -18.43% | 14.09% | 11.39% | 1.42% | -0.68% | -4.61% | 6.96% | 3.93% | -5.49% |
| 2022 | 7.31% | 1.44% | 4.04% | -6.55% | 3.37% | -6.83% | 0.73% | 2.52% | -5.52% | 20.45% | 5.48% | -5.65% | 19.23% |
| 2021 | 2.56% | 20.75% | 5.54% | 4.67% | 3.46% | -8.43% | -3.59% | 8.31% | -0.44% | 1.73% | -5.89% | 6.53% | 37.43% |
Benchmark Metrics
MetLife, Inc. has an annualized alpha of 7.06%, beta of 1.35, and R2 of 0.45 versus S&P 500 Index. Calculated based on daily prices since April 05, 2000.
- This stock captured 130.61% of S&P 500 Index gains and 107.97% of its losses - amplifying both gains and losses, but participating more in upside than downside.
- R2 of 0.45 means the benchmark explains less than half of this stock's behavior - treat beta with caution or consider switching to a more representative benchmark.
- Alpha
- 7.06%
- Beta
- 1.35
- R²
- 0.45
- Upside Capture
- 130.61%
- Downside Capture
- 107.97%
Return for Risk
Risk / Return Rank
MET ranks 58 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for MetLife, Inc. (MET) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MET | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.43 | ||
| Sortino ratioReturn per unit of downside risk | -1.82 | ||
| Omega ratioGain probability vs. loss probability | 1.12 | 1.37 | -0.25 |
| Calmar ratioReturn relative to maximum drawdown | 0.80 | 2.78 | -1.99 |
| Martin ratioReturn relative to average drawdown | 2.16 | 12.44 | -10.28 |
Dividends
Dividend History
MetLife, Inc. provided a 2.62% dividend yield over the last twelve months, with an annual payout of $2.30 per share. The company has been increasing its dividends for 7 consecutive years.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $2.30 | $2.25 | $2.16 | $2.06 | $1.98 | $1.90 | $1.82 | $1.74 | $1.66 | $7.34 | $1.40 | $1.31 |
Dividend yield | 2.62% | 2.85% | 2.63% | 3.12% | 2.74% | 3.04% | 3.88% | 3.41% | 4.04% | 14.52% | 2.92% | 3.06% |
Monthly Dividends
The table displays the monthly dividend distributions for MetLife, Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.57 | $0.00 | $0.00 | $0.59 | $0.00 | $1.16 | ||||||
| 2025 | $0.00 | $0.55 | $0.00 | $0.00 | $0.57 | $0.00 | $0.00 | $0.57 | $0.00 | $0.00 | $0.57 | $0.00 | $2.25 |
| 2024 | $0.00 | $0.52 | $0.00 | $0.00 | $0.55 | $0.00 | $0.00 | $0.55 | $0.00 | $0.00 | $0.55 | $0.00 | $2.16 |
| 2023 | $0.00 | $0.50 | $0.00 | $0.00 | $0.52 | $0.00 | $0.00 | $0.52 | $0.00 | $0.00 | $0.52 | $0.00 | $2.06 |
| 2022 | $0.00 | $0.48 | $0.00 | $0.00 | $0.50 | $0.00 | $0.00 | $0.50 | $0.00 | $0.00 | $0.50 | $0.00 | $1.98 |
| 2021 | $0.00 | $0.46 | $0.00 | $0.00 | $0.48 | $0.00 | $0.00 | $0.48 | $0.00 | $0.00 | $0.48 | $0.00 | $1.90 |
Dividend Yield & Payout
Dividend Yield
MetLife, Inc. has a dividend yield of 2.62%, which is quite average when compared to the overall market.
Payout Ratio
MetLife, Inc. has a payout ratio of 47.06%, which is quite average when compared to the overall market. This suggests that MetLife, Inc. strikes a balance between reinvesting profits for growth and paying dividends to shareholders.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the MetLife, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the MetLife, Inc. was 82.37%, occurring on Mar 5, 2009. Recovery took 1955 trading sessions.
The current MetLife, Inc. drawdown is 1.44%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
Financial crisis2007–2009 | -82.37%Mar 2009 | 1y 4mo | 7y 9mo | 9y 2moOct 2007 - Dec 2016 |
COVID crash2020 | -55.16%Mar 2020 | 1mo 9d | 9mo 27d | 11mo 6dFeb 2020 - Jan 2021 |
Dot-com crash2000–2002 | -42.73%Oct 2002 | 1y 10mo | 1y 4mo | 3y 2moDec 2000 - Mar 2004 |
2023 bear market2023 | -35.09%May 2023 | 5mo 19d | 10mo 16d | 1y 4moNov 2022 - Mar 2024 |
Rate-hike selloffLate 2018 | -28.31%Dec 2018 | 1y 1mo | 1y 9d | 2y 2moNov 2017 - Jan 2020 |
Drawdown Indicators
| MET | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -82.37% | -56.78% | -25.59% |
Max Drawdown (1Y)Largest decline over 1 year | -17.46% | -9.10% | -8.36% |
Max Drawdown (3Y)Largest decline over 3 years | -21.97% | -18.90% | -3.07% |
Max Drawdown (5Y)Largest decline over 5 years | -35.09% | -25.43% | -9.66% |
Max Drawdown (10Y)Largest decline over 10 years | -55.16% | -33.92% | -21.24% |
Current DrawdownCurrent decline from peak | -1.44% | -1.80% | +0.36% |
Average DrawdownAverage peak-to-trough decline | -17.61% | -10.71% | -6.90% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.42% | 2.03% | +4.39% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of MetLife, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how MetLife, Inc. is priced in the market compared to other companies in the Insurance - Life industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for MET, comparing it with other companies in the Insurance - Life industry. Currently, MET has a P/E ratio of 12.2. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for MET compared to other companies in the Insurance - Life industry. MET currently has a PEG ratio of 0.4. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for MET relative to other companies in the Insurance - Life industry. Currently, MET has a P/S ratio of 0.6. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with MET
Add MetLife, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with MET